Learn more about #NiemannPick Disease Type C and how the buildup of cholesterol inside cells plays a primary role in disease progression. https://bit.ly/44t6U5P #NPC1 #NPC
Cyclo Therapeutics, Inc.
Pharmaceutical Manufacturing
Gainesville, Florida 1,806 followers
Dedicated to developing life-changing medicines for patients and families living with challenging diseases
About us
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is conducting a Phase 2b clinical trial using Trappsol® Cyclo™ intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. For additional information, visit the Company’s website: www.cyclotherapeutics.com.
- Website
-
https://www.cyclotherapeutics.com/
External link for Cyclo Therapeutics, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Gainesville, Florida
- Type
- Public Company
- Founded
- 1990
- Specialties
- cyclodextrins, cyclodextrin derivatives, cyclodextrin complexes, cyclodextrin chemistry, hydroxypropyl, gamma, Trappsol(R), Cyclo(TM), and Aquaplex(R)
Locations
-
Primary
Get directions
6714 NW 16th St
Gainesville, Florida, US
Employees at Cyclo Therapeutics, Inc.
Updates
-
Andreas Brecht from our Medical Affairs team recently joined the #NiemannPick community in Switzerland for their annual patients and caregivers gathering. As always, #thankyou to the #NPC community for allowing us to be a part of their thoughtful discussions.
-
-
We are committed to working closely with patients, families, caregivers and advocacy groups to provide support, connections and resources. Access helpful resources here: https://bit.ly/472wsaF #NiemannPick #AlzheimersDisease
Patient Resources - cyclotherapeutics
-
Global engagement with the #NPC community is a key component to developing a safe and effective treatment option for patients. We are proud to be a Platinum Sponsor for the Australian NPC Foundation 2024 Conference. https://bit.ly/3Pp8kZV #NiemannPick
NPC Conference | Australian NPC Disease Foundation Inc
npcd.org.au
-
We are committed to patient focused drug development for an underserved patient community. #NiemamnnPick #NPC1 #NPC
-
-
We are honored to be a gold sponsor for the Latin American School of Medical and Human Genetics annual meeting in Brazil. Professor Roberto Giugliani, MD, PhD of our global steering committee is chair of this important event. https://Bit.ly/3STzHfo #NiemannPick
-
-
Receive instant updates and notifications about our latest news and events. Sign up for email alerts today: https://bit.ly/44RHGgU #NiemannPick #NPC1 #NPC
-
-
Never miss a beat with instant email notifications from us! Sign up today: https://bit.ly/44RHGgU #NiemannPick #NPC #AlzheimersDisease
-
-
#NiemannPick is a rare, fatal and progressive genetic disorder in need of safe and effective treatment options. Learn more: https://bit.ly/44t6U5P #NiemannPick #NPC1 #RareDisease
-